TP53 and triple-negative breast carcinoma: Mining of RNAseq data of patient tumor samples with endogenous p53 DNA contact or conformational mutations revealed no statistically significant differences in ROCK1 or ROCK2 expression levels in a TCGA dataset of triple-negative breast cancer (TNBC)s, a subtype with a high frequency of p53 missense mutations49(Supplementary Fig. 13a).